Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Leishmania major | putative PfkB family sugar kinase | 0.0083 | 0.023 | 1 |
Brugia malayi | Ribokinase | 0.0083 | 0.023 | 0.023 |
Leishmania major | adenosine kinase-like protein | 0.0083 | 0.023 | 1 |
Entamoeba histolytica | fructokinase, putative | 0.0083 | 0.023 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Schistosoma mansoni | ribokinase | 0.0083 | 0.023 | 1 |
Mycobacterium tuberculosis | Ribokinase RbsK | 0.0083 | 0.023 | 0.5 |
Mycobacterium ulcerans | carbohydrate kinase CbhK | 0.0083 | 0.023 | 0.5 |
Trichomonas vaginalis | ribokinase, putative | 0.0083 | 0.023 | 1 |
Mycobacterium tuberculosis | Adenosine kinase | 0.0083 | 0.023 | 0.5 |
Leishmania major | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Plasmodium falciparum | cyclin | 0.0034 | 0 | 0.5 |
Onchocerca volvulus | Ribokinase homolog | 0.0083 | 0.023 | 0.023 |
Entamoeba histolytica | kinase, PfkB family | 0.0083 | 0.023 | 1 |
Entamoeba histolytica | Hypothetical protein T24C12.3, putative | 0.0083 | 0.023 | 1 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0083 | 0.023 | 1 |
Leishmania major | adenosine kinase-like protein | 0.0083 | 0.023 | 1 |
Brugia malayi | Adenosine kinase-like | 0.0083 | 0.023 | 0.023 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0083 | 0.023 | 1 |
Trichomonas vaginalis | ribokinase, putative | 0.0083 | 0.023 | 1 |
Giardia lamblia | Ribokinase | 0.0083 | 0.023 | 1 |
Onchocerca volvulus | 0.2177 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.023 | 0.023 |
Trypanosoma cruzi | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.023 | 0.023 |
Entamoeba histolytica | tagatose-6-phosphate kinase, putative | 0.0083 | 0.023 | 1 |
Leishmania major | ribokinase, putative | 0.0083 | 0.023 | 1 |
Echinococcus granulosus | ribokinase | 0.0083 | 0.023 | 1 |
Onchocerca volvulus | Putative pyridoxal kinase | 0.0083 | 0.023 | 0.023 |
Trypanosoma brucei | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Trichomonas vaginalis | ribokinase, putative | 0.0083 | 0.023 | 1 |
Schistosoma mansoni | adenosine kinase | 0.0083 | 0.023 | 1 |
Toxoplasma gondii | kinase, pfkB family protein | 0.0083 | 0.023 | 0.5 |
Trypanosoma brucei | adenosine kinase, putative | 0.0083 | 0.023 | 1 |
Mycobacterium leprae | Probable adenosine kinase adk | 0.0083 | 0.023 | 0.5 |
Echinococcus multilocularis | ribokinase | 0.0083 | 0.023 | 1 |
Entamoeba histolytica | ribokinase, putative | 0.0083 | 0.023 | 1 |
Toxoplasma gondii | kinase, pfkB family protein | 0.0083 | 0.023 | 0.5 |
Leishmania major | tagatose-6-phosphate kinase-like protein | 0.0083 | 0.023 | 1 |
Mycobacterium tuberculosis | 6-phosphofructokinase PfkB (phosphohexokinase) (phosphofructokinase) | 0.0083 | 0.023 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2177 | 1 | 1 |
Echinococcus granulosus | adenosine kinase | 0.0083 | 0.023 | 1 |
Schistosoma mansoni | adenosine kinase | 0.0083 | 0.023 | 1 |
Echinococcus multilocularis | pseudouridine metabolizing bifunctional protein | 0.0083 | 0.023 | 1 |
Echinococcus granulosus | pseudouridine metabolizing bifunctional protein | 0.0083 | 0.023 | 1 |
Echinococcus multilocularis | adenosine kinase | 0.0083 | 0.023 | 1 |
Trypanosoma cruzi | ribokinase, putative | 0.0083 | 0.023 | 1 |
Trypanosoma brucei | ribokinase, putative | 0.0083 | 0.023 | 1 |
Trypanosoma brucei | ribokinase, putative | 0.0083 | 0.023 | 1 |
Mycobacterium ulcerans | fructokinase, PfkB | 0.0083 | 0.023 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.863 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.841 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.417 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.409 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.36 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.209 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.188 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.118 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.003 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.001 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.